Medifast, Inc. Restructuring Costs and Asset Impairment Charges
Medifast, Inc. (MED) reported Restructuring Costs and Asset Impairment Charges of $12.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-02-17
- Medifast, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-12-31 was $0.00.
- Medifast, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-09-30 was $0.00.
- Medifast, Inc. restructuring costs and asset impairment charges for the quarter ending 2024-06-30 was $12.50M.
- Medifast, Inc. restructuring costs and asset impairment charges for fiscal 2025 was $12.50M, a 0.00% change from fiscal 2024.
- Medifast, Inc. restructuring costs and asset impairment charges for fiscal 2024 was $12.50M.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.50M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $12.50M derived: sum of 3 quarters · filed 2026-02-17 | $12.50M 10-K · filed 2026-02-17 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 | $12.50M derived: sum of 2 quarters · filed 2024-11-04 | $12.50M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $12.50M 10-Q · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |